115 related articles for article (PubMed ID: 326069)
1. Immunological studies in human schistosomiasis. III. Immunoglobulin levels, antibodies, and delayed hypersensitivity.
Camus D; Carlier Y; Capron M; Bina JC; Figueiredo JF; Prata A; Capron A
Am J Trop Med Hyg; 1977 May; 26(3):482-90. PubMed ID: 326069
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune responses in human hepatosplenic schistosomiasis mansoni.
Goodgame RW; Colley DG; Draper CC; Lewis FA; McLaren ML; Pelley RP
Am J Trop Med Hyg; 1978 Nov; 27(6):1174-80. PubMed ID: 727322
[TBL] [Abstract][Full Text] [Related]
3. The role of circulating immune complexes in the glomerular disease of experimental hepatosplenic schistosomiasis.
Digeon M; Droz D; Noel LH; Riza J; Rieumailhol C; Bach JF; Santoro F; Capron A
Clin Exp Immunol; 1979 Mar; 35(3):329-37. PubMed ID: 378479
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulins in patients with schistosomiasis mansoni.
Guimarães RX; Prícoli TI; Novo NF; de Paiva ER
Arq Gastroenterol; 1979; 16(1):3-7. PubMed ID: 475612
[TBL] [Abstract][Full Text] [Related]
5. Immune responses during human schistosomiasis mansoni. IX. T-lymphocyte subset analysis by monoclonal antibodies in hepatosplenic disease.
Colley DG; Katz N; Rocha RS; Abrantes W; da Silva AL; Gazzinelli G
Scand J Immunol; 1983 Apr; 17(4):297-302. PubMed ID: 6601292
[TBL] [Abstract][Full Text] [Related]
6. Modulation of granulomatous hypersensitivity. IV. Immunoglobulin and antibody production by vigorous and immunomodulated liver granulomas of Schistosoma mansoni-infected mice.
Boros DL; Amsden AF; Hood AT
J Immunol; 1982 Mar; 128(3):1050-3. PubMed ID: 7035555
[TBL] [Abstract][Full Text] [Related]
7. Histopathological and immunofluorescence study of the choroid plexus in hepatosplenic schistosomiasis mansoni.
Pittella JE; Bambirra EA
Am J Trop Med Hyg; 1989 Nov; 41(5):548-52. PubMed ID: 2510526
[TBL] [Abstract][Full Text] [Related]
8. Chronic human schistosomiasis mansoni-schistosomal antigen, immunoglobulins and complement C3 detection in the liver.
De Brito T; Shimizu SH; Yamashiro E; Da Silva LC
Liver; 1985 Apr; 5(2):64-70. PubMed ID: 3889530
[TBL] [Abstract][Full Text] [Related]
9. Suppression of mitogen-induced lymphocyte transformation by plasma from patients with hepatosplenic Schistosomiasis mansoni: role of immune complexes.
Kamal KA; Higashi GI
Parasite Immunol; 1982 Jul; 4(4):283-98. PubMed ID: 6812000
[TBL] [Abstract][Full Text] [Related]
10. Cell mediated immune (CMI) responsiveness to soluble egg antigen (SEA) and its relation to the occurrence of schistosomal hepatosplenic disease in patients with schistosomiasis mansoni.
Helmy-Khalil S; Fahmy MH; Ghanem MH; Said M; El Sawy M; Nofal M; Awadalla HN; Youssef M; Mucke D; Brock J
Tropenmed Parasitol; 1979 Dec; 30(4):426-8. PubMed ID: 538816
[TBL] [Abstract][Full Text] [Related]
11. Immunological studies in human schistosomiasis. II. Antibodies cytotoxic for Schistosoma mansoni schistosomules.
Capron M; Camus D; Carlier Y; Figueiredo JF; Capron A
Am J Trop Med Hyg; 1977 Mar; 26(2):248-53. PubMed ID: 848648
[TBL] [Abstract][Full Text] [Related]
12. [Hypersensitivity in human schistosomiasis due to Schistosoma mansoni and Schistosoma haematobium. II. In vitro study of the lethal activity of patient sera for schistosomules of S. mansoni. Relation to hypersensitivity tests].
Capron A; Capron M; Camus D; Vernes A
Pathol Biol (Paris); 1973 Dec; 21(10):1079-84. PubMed ID: 4589580
[No Abstract] [Full Text] [Related]
13. Class specific antibodies and fluorescent staining patterns in acute and chronic forms of schistosomiasis mansoni.
Kanamura HY; Hoshino-Shimizu S; Camargo ME; da Silva LC
Am J Trop Med Hyg; 1979 Mar; 28(2):242-8. PubMed ID: 378002
[TBL] [Abstract][Full Text] [Related]
14. Antibodies sequestered in the liver granulomata of 8-week infections of CF1 mice by Schistosoma mansoni Sambon, 1907.
Sogandares-Bernal F; Brandt S
Z Parasitenkd; 1976 Oct; 50(3):331-4. PubMed ID: 997726
[TBL] [Abstract][Full Text] [Related]
15. Immune profiles in hepatosplenic schistosomiasis mansoni after surgical treatments.
Petroianu A; Antunes LJ
J Int Med Res; 1998; 26(1):43-9. PubMed ID: 9513076
[TBL] [Abstract][Full Text] [Related]
16. [Humoral immune response to typhoid vaccine in hepatosplenic schistosomiasis mansoni].
Shikanai Yasuda MA; Yasuda PH; Ferri RG; de Castilho EA; Shiroma M
Rev Inst Med Trop Sao Paulo; 1982; 24(4):198-204. PubMed ID: 7156703
[No Abstract] [Full Text] [Related]
17. Immunological changes in splenectomized versus non splenectomized schistosomal hepatosplenic cases.
Salem SA; Makled MK; Abel-Wahab MF; Sedky A; Montasser MF; Bishara SA; Ragheb MM; Younis TA
J Egypt Soc Parasitol; 1987 Dec; 17(2):785-96. PubMed ID: 3121771
[No Abstract] [Full Text] [Related]
18. Hepatosplenic schistosomiasis mansoni: an immunologic disease.
Warren KS
Bull N Y Acad Med; 1975 Apr; 51(4):545-50. PubMed ID: 1091317
[No Abstract] [Full Text] [Related]
19. Host and parasite determinants of morbidity in Egyptian children with schistosomiasis.
Hussein HM; Kaddah MA; el-Borai YA; el Batanony GA; Abdel Ghafar FA; Zakaria S
J Egypt Soc Parasitol; 1996 Dec; 26(3):755-72. PubMed ID: 8918048
[TBL] [Abstract][Full Text] [Related]
20. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
